Xeris Biopharma Preparing for Upcoming Financial Results Call
Xeris Biopharma Plans Financial Results Announcement
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS) has exciting news for investors and stakeholders alike. This growth-focused biopharmaceutical company is dedicated to enhancing patients' lives through the development and marketing of innovative therapies. They've announced their intention to release third quarter 2024 financial results before the markets open on a notable day in November.
Conference Call Details
On the designated date, Xeris management will host a conference call and webcast at 8:30 a.m. Eastern Time. This session will provide a comprehensive overview of the company’s financial and operational performance for the quarter. Stakeholders are encouraged to tune in to learn more about the company's milestones and future outlook.
How to Pre-register for the Call
Interested parties can pre-register for the conference call by visiting the dedicated link provided in the company's official announcements. It is advisable to register at least ten minutes prior to the start to ensure a smooth entry into the session. Participants will receive a confirmation email with important dial-in information and a unique entry code.
Replay and Access Information
For those who are unable to attend the live call, a replay will be accessible for a limited time. Callers can access the replay through various numbers tailored for different locations, ensuring everyone has the opportunity to stay informed about the company's developments.
About Xeris Biopharma Holdings
Xeris stands committed to developing and commercializing a diverse range of innovative products aimed at treating various health concerns. Currently, their portfolio includes three commercially available products. Notable among them is Gvoke®, a ready-to-use liquid glucagon designed to counter severe hypoglycemia.
Pipeline of Innovative Therapies
Additionally, Xeris offers Keveyis®, a proven treatment for primary periodic paralysis, alongside Recorlev®, which is used in managing endogenous Cushing’s syndrome. The company continues to expand its product range with a robust pipeline that leverages its proprietary formulation technologies, XeriSol™ and XeriJect®. This strategic approach allows Xeris to create therapies that are not only effective but also user-friendly.
Company Mission and Vision
Located in Chicago, Xeris Biopharma is deeply rooted in its mission to improve patients' lives. The company strives to enhance medication delivery methods, making treatments more accessible and manageable for patients with chronic conditions. Their innovative mindset positions them as key players in the biopharmaceutical landscape, and they are consistently seeking new opportunities to expand their influence.
Frequently Asked Questions
What is the date of the upcoming financial results announcement?
The financial results for the third quarter of 2024 will be announced before the market opens on November 8, 2024.
Will there be a conference call?
Yes, there will be a conference call hosted by Xeris Biopharma management on the same day at 8:30 a.m. Eastern Time.
How can I participate in the conference call?
Participants can pre-register for the call through the link provided in the financial announcement and should do so at least ten minutes prior to the start.
What products are included in Xeris' portfolio?
Xeris offers Gvoke®, Keveyis®, and Recorlev®, addressing various medical needs in the biopharmaceutical sector.
What is the company’s focus?
Xeris focuses on developing innovative therapies that enhance patients’ lives through improved product formulation and delivery methods.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
